Selective inhibition of mammalian lanosterol 14 alpha-demethylase: a possible strategy for cholesterol lowering. 1993

K A Walker, and D J Kertesz, and D M Rotstein, and D C Swinney, and P W Berry, and O Y So, and A S Webb, and D M Watson, and A Y Mak, and P M Burton
Syntex Discovery Research, Palo Alto, California 94304.

UI MeSH Term Description Entries
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

K A Walker, and D J Kertesz, and D M Rotstein, and D C Swinney, and P W Berry, and O Y So, and A S Webb, and D M Watson, and A Y Mak, and P M Burton
August 1995, Biochemical pharmacology,
K A Walker, and D J Kertesz, and D M Rotstein, and D C Swinney, and P W Berry, and O Y So, and A S Webb, and D M Watson, and A Y Mak, and P M Burton
November 2001, Archives of biochemistry and biophysics,
K A Walker, and D J Kertesz, and D M Rotstein, and D C Swinney, and P W Berry, and O Y So, and A S Webb, and D M Watson, and A Y Mak, and P M Burton
January 1988, The Journal of biological chemistry,
K A Walker, and D J Kertesz, and D M Rotstein, and D C Swinney, and P W Berry, and O Y So, and A S Webb, and D M Watson, and A Y Mak, and P M Burton
August 2003, American journal of respiratory cell and molecular biology,
K A Walker, and D J Kertesz, and D M Rotstein, and D C Swinney, and P W Berry, and O Y So, and A S Webb, and D M Watson, and A Y Mak, and P M Burton
October 1990, Biochemical Society transactions,
K A Walker, and D J Kertesz, and D M Rotstein, and D C Swinney, and P W Berry, and O Y So, and A S Webb, and D M Watson, and A Y Mak, and P M Burton
July 1995, Biological & pharmaceutical bulletin,
K A Walker, and D J Kertesz, and D M Rotstein, and D C Swinney, and P W Berry, and O Y So, and A S Webb, and D M Watson, and A Y Mak, and P M Burton
May 1991, Biochemical and biophysical research communications,
K A Walker, and D J Kertesz, and D M Rotstein, and D C Swinney, and P W Berry, and O Y So, and A S Webb, and D M Watson, and A Y Mak, and P M Burton
January 1998, Journal of enzyme inhibition,
K A Walker, and D J Kertesz, and D M Rotstein, and D C Swinney, and P W Berry, and O Y So, and A S Webb, and D M Watson, and A Y Mak, and P M Burton
August 1991, Biochemical Society transactions,
K A Walker, and D J Kertesz, and D M Rotstein, and D C Swinney, and P W Berry, and O Y So, and A S Webb, and D M Watson, and A Y Mak, and P M Burton
August 1995, Biochemistry,
Copied contents to your clipboard!